Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label, Randomized, Controlled, With Blind Assessor, Study to Assess Efficacy and Safety of Rheosorbilact®, Solution for Infusion ("Yuria-Pharm"), in Comparison With Ringer's Lactate,Solution for Infusion, in a Complex Therapy of Burns

NCT04152096 is registered in ClinicalTrials.gov with Yuria-Pharm as lead sponsor.

NCT NCT04152096
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04152096 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label, Randomized, Controlled, With Blind Assessor, Study to Assess Efficacy and Safety of Rheosorbilact®, Solution for Infusion ("Yuria-Pharm"), in Comparison With Ringer's Lactate,Solution for Infusion, in a Complex Therapy of Burns
Lead sponsor
Yuria-Pharm
Phase
Phase 4
Overall status
Completed
Start date
February 2, 2017
Completion date
May 12, 2021
Enrollment
118 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

burns, intoxication